CIR Support For Ingredient Immune, Hormonal Effects Screening Urged
This article was originally published in The Rose Sheet
Executive Summary
Cosmetic ingredient screening data on immune suppression and enhancement effects on skin should become a more regular element of safety assessments conducted by the Cosmetic Ingredient Review Expert Panel in the future, outgoing panelist Arnold Schroeter, MD, said at a CIR meeting in Washington, D.C. June 4-5.